DK2709633T3 - Fremgangsmåde til behandling eller profylakse af bakteriel vaginose - Google Patents

Fremgangsmåde til behandling eller profylakse af bakteriel vaginose Download PDF

Info

Publication number
DK2709633T3
DK2709633T3 DK11865925T DK11865925T DK2709633T3 DK 2709633 T3 DK2709633 T3 DK 2709633T3 DK 11865925 T DK11865925 T DK 11865925T DK 11865925 T DK11865925 T DK 11865925T DK 2709633 T3 DK2709633 T3 DK 2709633T3
Authority
DK
Denmark
Prior art keywords
prophylaxy
treatment
bacterial vaginosis
vaginosis
bacterial
Prior art date
Application number
DK11865925T
Other languages
English (en)
Inventor
Jeremy Robert Arthur Paull
Jacinth Kincaid Fairley
Clare Frances Price
Gareth Rhys Lewis
Original Assignee
Starpharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Starpharma Pty Ltd filed Critical Starpharma Pty Ltd
Application granted granted Critical
Publication of DK2709633T3 publication Critical patent/DK2709633T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/795Polymers containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pregnancy & Childbirth (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK11865925T 2011-05-16 2011-07-14 Fremgangsmåde til behandling eller profylakse af bakteriel vaginose DK2709633T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161486700P 2011-05-16 2011-05-16
PCT/AU2011/000891 WO2012155172A1 (en) 2011-05-16 2011-07-14 Method of treatment or prophylaxis of bacterial vaginosis

Publications (1)

Publication Number Publication Date
DK2709633T3 true DK2709633T3 (da) 2019-11-11

Family

ID=47176018

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11865925T DK2709633T3 (da) 2011-05-16 2011-07-14 Fremgangsmåde til behandling eller profylakse af bakteriel vaginose

Country Status (23)

Country Link
US (1) US9155760B2 (da)
EP (1) EP2709633B1 (da)
JP (2) JP6057987B2 (da)
KR (2) KR20180126621A (da)
CN (2) CN103687601B (da)
AU (1) AU2011368322B2 (da)
BR (1) BR112013029661B1 (da)
CA (1) CA2836168C (da)
CY (1) CY1122258T1 (da)
DK (1) DK2709633T3 (da)
ES (1) ES2753531T3 (da)
HK (1) HK1247572A1 (da)
HR (1) HRP20191888T1 (da)
HU (1) HUE047170T2 (da)
IL (1) IL229439A (da)
LT (1) LT2709633T (da)
MX (1) MX361009B (da)
PL (1) PL2709633T3 (da)
PT (1) PT2709633T (da)
RS (1) RS59598B1 (da)
RU (1) RU2632110C2 (da)
SI (1) SI2709633T1 (da)
WO (1) WO2012155172A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2884897C (en) 2012-09-13 2021-07-27 Starpharma Pty Limited Method of treatment or prophylaxis of infections of the eye
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸
CA2988082C (en) 2015-06-01 2020-09-29 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
EP3930730A4 (en) * 2020-04-15 2022-05-11 Starpharma Pty Limited PROPHYLAXIS FOR CORONAVIRUS AND/OR RESPIRATORY SYNCYTIAL VIRUS INFECTION

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
AUPP584298A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Antimicrobial and antiparasitic agents
US7572459B2 (en) * 1998-09-14 2009-08-11 Starpharma Pty Ltd. Anionic or cationic dendrimer antimicrobial or antiparasitic compositions
AUPR412801A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agent for the prevention and treatment of sexually transmitted disease s - I
PL1937284T3 (pl) * 2005-10-18 2016-05-31 Starpharma Pty Ltd System podawania kompozycji bakteriobójczego dendymeru
CN101405010B (zh) * 2006-03-22 2013-03-06 星药股份有限公司 避孕组合物

Also Published As

Publication number Publication date
PL2709633T3 (pl) 2020-03-31
ES2753531T3 (es) 2020-04-13
PT2709633T (pt) 2019-11-18
CN107669698A (zh) 2018-02-09
MX2013013473A (es) 2014-06-05
US20120295839A1 (en) 2012-11-22
EP2709633A4 (en) 2014-10-15
IL229439A0 (en) 2014-01-30
CY1122258T1 (el) 2020-11-25
WO2012155172A1 (en) 2012-11-22
HK1247572A1 (zh) 2018-09-28
BR112013029661A2 (pt) 2020-10-06
US9155760B2 (en) 2015-10-13
CN103687601A (zh) 2014-03-26
RU2632110C2 (ru) 2017-10-02
KR20140040750A (ko) 2014-04-03
AU2011368322B2 (en) 2016-07-21
KR102096114B1 (ko) 2020-04-02
CN103687601B (zh) 2017-12-08
CA2836168A1 (en) 2012-11-22
EP2709633B1 (en) 2019-09-04
KR20180126621A (ko) 2018-11-27
BR112013029661B1 (pt) 2021-10-13
RS59598B1 (sr) 2020-01-31
CA2836168C (en) 2019-09-24
SI2709633T1 (sl) 2020-01-31
HRP20191888T1 (hr) 2020-01-24
AU2011368322A1 (en) 2013-05-02
IL229439A (en) 2017-09-28
JP2014515032A (ja) 2014-06-26
HUE047170T2 (hu) 2020-04-28
RU2013155620A (ru) 2015-06-27
LT2709633T (lt) 2019-11-25
JP2016193945A (ja) 2016-11-17
MX361009B (es) 2018-11-15
EP2709633A1 (en) 2014-03-26
JP6057987B2 (ja) 2017-01-11

Similar Documents

Publication Publication Date Title
DK2906698T3 (da) Fremgangsmåde til behandling af alports syndrom
DK2707029T3 (da) Fremgangsmåder til at behandle eller forebygge kolesterolrelaterede sygdomme
DK2553113T3 (da) FREMGANGSMÅDE TIL FREMSTILLING AF L-ORNITHIN UNDER ANVENDELSE AF LysE-OVEREKSPRIMERENDE BAKTERIER
DK2776567T3 (da) Sammensætninger og fremgangsmåder til behandling af cytomegalovirus.
DK3581199T3 (da) Fremgangsmåder til behandling eller reduktion af ødematøs fibrosklerotisk pannikulitis
BR112013021373A2 (pt) aparelho e método de bebida preparada
BR112013033633A2 (pt) método de formação de um laminado elástico
DK2791367T3 (da) Mutante mikroorganismer til syntetisering af colansyre, mannosylerede og/eller fucosylerede oligosaccharider
EP2773754A4 (en) Methods of Treatment
BR112015013188A2 (pt) método de fermentação otimizado
DK2768321T3 (da) Fremgangsmåder og sammensætninger til induktion af mæthed
BR112014007958A2 (pt) método
DK2622532T3 (da) Fremgangsmåde til kollaborativ beregning
BR112014001237A2 (pt) método
DK3141548T3 (da) Fremgangsmåder og mellemprodukter til fremstilling af azaindoler
BR112014001851A2 (pt) método
BR112014010450A2 (pt) composição e método
BR112014009795A2 (pt) método
BR112013022820A2 (pt) método de tratamento
DK2646011T3 (da) Fremgangsmåder til reduktion af overspisning eller tvangsspisning
IT1403906B1 (it) Apparato e metodo per realizzare sbozzati
DK2701707T3 (da) Fremgangsmåde til behandling af dyskinesi
BR112014010860A2 (pt) composição e método
BR112013034066A2 (pt) método de administração e tratamento
BR112014002804A2 (pt) revestimento e método de preparação do mesmo